Therapeutic options for hypertriglyceridaemia: the future.
Topic:
Primary cardiovascular prevention: interventions and outcomes
Speaker:
Professor J. Chapman (Paris, FR)
Organised by University Hospital, Umea / Course Director: Ulf Naeslund / Supported by an unrestricted educational grant from AstraZeneca
Event:
ESC CONGRESS 2014
About the speaker
Professor John Chapman
Pitie Salpetriere APHP University Hospital, Paris (France)
17
presentations
0
follower
4 more presentations in this session
Discussion and closing remarks - Triglycerides and cardiovascular risk.
Speaker: Professor J. Chapman (Paris, FR)
Access the full session
Triglycerides and cardiovascular risk: the importance of treating hypertriglyceridaemia
Speakers:
Professor J. Chapman, Professor J. Chapman, Professor E. Stroes, Professor B. Nordestgaard, Professor J. Chapman
About the event
ESC 365 is supported by
